Cyclophosphamide Versus Rituximab in Progressive Forms of Multiple Sclerosis
This study aimed to compare the efficacy of rituximab versus Cyclophosphamide on active secondary progressive multiple sclerosis (SPMS). The randomized clinical trial was performed from 2015 to 2017 in multiple sclerosis (MS) clinics affiliated to Isfahan MS society (IMSS). Patients were randomized...
Main Authors: | Masoud Etemadifar, Shadi Ghourchian, Nazanin Mahinparvar, Mehri Salari, Fatemeh Etemadifar, Yalda Nikanpour, Shahin Sanaei, Mojtaba Akbari |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2020-02-01
|
Series: | Acta Medica Iranica |
Subjects: | |
Online Access: | https://acta.tums.ac.ir/index.php/acta/article/view/8096 |
Similar Items
-
Rituximab Therapy for Severe Cutaneous Leukocytoclastic Angiitis Refractory to Corticosteroids, Cellcept and Cyclophosphamide
by: Kamel El-Reshaid, et al.
Published: (2013-04-01) -
Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly
by: Roberta Fenoglio, et al.
Published: (2020-10-01) -
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
by: Frank B. Cortazar, et al.
Published: (2018-03-01) -
Response to cyclophosphamide and rituximab therapy in idiopathic inflammatory myopathies: A single center experience
by: Amira A. Shahin, et al.
Published: (2021-06-01) -
Rituximab induced cytokine release syndrome in an MS patient: A case report
by: Masoud Etemadifar, et al.
Published: (2021-07-01)